Equities

Protext Mobility Inc

TXTM:PKC

Protext Mobility Inc

Actions
TechnologyTechnology
  • Price (USD)0.0013
  • Today's Change0.000 / -3.70%
  • Shares traded7.08m
  • 1 Year change+44.44%
  • Beta-3.3577
Data delayed at least 15 minutes, as of Nov 21 2024 20:58 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Protext Mobility, Inc. is a biotech company, which is engaged in the development of a cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes and technologies. The Company is engaged in the research, testing and development of highly bioavailable botanical products all-natural ingredients formulated for nutraceutical and pharmaceutical applications through the use of proprietary live plant extraction technology. The Company’s subsidiaries include Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc.

  • Revenue in USD (TTM)750.00
  • Net income in USD-2.21m
  • Incorporated2010
  • Employees4.00
  • Location
    Protext Mobility Inc1100 Brickell Bay Drive 310747MIAMI 33231United StatesUSA
  • Phone+1 (516) 802-0223
  • Fax+1 (302) 655-5049
  • Websitehttp://ww1.protextm.co/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Indaptus Therapeutics Inc0.00-14.89m10.81m7.00--1.77-----1.72-1.720.000.58870.00----0.00-114.42-66.55-138.96-81.23------------0.00-------7.68------
Nascent Biotech Inc0.00-1.92m10.93m-----------0.012-0.0120.00-0.0030.00-------1,256.81-708.50-----------589.83------------25.47------
ELEVAI Labs Inc2.45m-5.47m11.08m18.00--0.1166--4.27-0.2924-0.29240.13030.17330.38260.9499216.67135,897.80-85.53---121.34--71.15---223.57--3.40--0.00--123.50---138.94------
NKGen Biotech Inc0.00-88.25m11.27m63.00---------3.74-3.740.00-2.710.00----0.00-480.25-----------------0.4822-----100.00---210.06------
Lyra Therapeutics Inc1.47m-97.61m11.65m87.00--0.5775--8.09-1.51-1.510.02290.3150.0148----16,715.91-97.94-58.01-118.22-68.69-----6,635.76-6,235.31----0.00--14.314.60-13.39--95.14--
Viaderma Inc17.80m2.31m11.72m75.000.00050.000031.980.60316.8416.84129.62255.590.412624.691.21237,331.305.36--6.53--28.90--12.99--2.075.660.1718---29.15---40.70------
Aspira Women's Health Inc8.92m-15.95m11.73m64.00------1.35-1.45-1.450.801-0.28921.5315.115.79139,421.90-273.16-110.58-3,758.30-151.8857.8445.23-178.80-334.080.5542-17,354.00----11.8524.5644.15---26.65--
Protext Mobility Inc750.00-2.21m11.87m4.00------15,238.12-0.4692-0.46920.00001-0.01020.0405-------9,400.97-1,587.94----86.67-530.19-232,392.00-17,498.830.0002-1.36-----93.98-63.0927.35------
Sol Gel Technologies Ltd11.71m-9.57m12.29m36.00--0.3814--1.13-0.3435-0.34350.42021.250.2522--3.34325,194.40-20.62-31.60-23.40-35.49-----81.75-135.76----0.00---59.9864.50-82.52---33.78--
Sensei Biotherapeutics Inc0.00-29.80m12.53m28.00--0.2659-----1.19-1.190.001.820.00----0.00-44.18-47.03-48.36-54.33------------0.0222------29.82--42.16--
AIM ImmunoTech Inc190.00k-23.93m12.74m26.00--4.27--70.98-0.4737-0.47370.00360.04960.0092----7,307.69-115.46-45.64-179.69-48.3581.05-231.75-12,594.21-11,695.01----0.484--43.26-11.26-48.94--35.73--
HST Global Inc0.00-123.45k12.80m1.00---------0.0209-0.02090.00-0.00040.00-------3,300.80-5,836.01---------------27.315.81-------0.7858------
Inhibitor Therapeutics Inc0.00-3.08m12.92m3.00--3.74-----0.0179-0.01790.000.01980.00----0.00-38.4227.48-38.9032.70------------0.000.00-----125.39------
NRX Pharmaceuticals Inc0.00-20.39m13.01m2.00---------1.69-1.690.00-1.650.00-------231.96-120.57---168.40-----------104.47--------24.14------
Data as of Nov 21 2024. Currency figures normalised to Protext Mobility Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.